A detailed history of Boothbay Fund Management, LLC transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 83,402 shares of CLBT stock, worth $1.81 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
83,402
Previous 48,296 72.69%
Holding current value
$1.81 Million
Previous $577,000 143.33%
% of portfolio
0.04%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.61 - $17.52 $407,580 - $615,057
35,106 Added 72.69%
83,402 $1.4 Million
Q2 2024

Aug 14, 2024

BUY
$10.38 - $12.5 $363,798 - $438,100
35,048 Added 264.55%
48,296 $577,000
Q1 2024

May 15, 2024

BUY
$8.04 - $12.29 $106,513 - $162,817
13,248 New
13,248 $146,000
Q3 2023

Nov 14, 2023

BUY
$6.86 - $8.18 $388,433 - $463,176
56,623 New
56,623 $433,000

Others Institutions Holding CLBT

About Cellebrite DI Ltd.


  • Ticker CLBT
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Infrastructure
  • Shares Outstandng 189,648,992
  • Market Cap $4.11B
  • Description
  • Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...
More about CLBT
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.